Lymphoma of the Retina and CNS

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 372-377

  Singh, Arun D ^a   Lewis, Hilel ^a   Schachat, Andrew P ^a   Peereboom, David ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37749026578     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50067-X     Document Type: Chapter

References (32)

1. Hochberg FH, Miller DC Primary central nervous system lymphoma. J Neurosurg 1988, 68:835-853.
2. DeAngelis LM Primary central nervous system lymphoma. Curr Opin Neurol 1999, 12:687-691.
3. Newell ME, Hoy JF, Cooper SG, et al. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 2004, 100:2627-2636.
4. Marshall AG, Pawson R, Thom M, et al. HTLV-I associated primary CNS T-cell lymphoma. J Neurol Sci 1998, 158:226-231.
5. Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol 2003, 241:860-870.
6. Choi JS, Nam DH, Ko YH, et al. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 2003, 27:919-928.
7. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002, 95:1504-1510.
8. Char DH, Ljung BM, Miller T, Phillips T Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988, 95:625-630.
9. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993, 100:1399-1406.
10. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987, 94:1631-1639.
11. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM The clinical spectrum of ocular lymphoma. Cancer 1993, 72:843-849.
12. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999, 106:1805-1810.
13. Gass JD, Sever RJ, Grizzard WS, et al. Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina 1984, 4:135-143.
14. Rishi K, Font RL, Chevez-Barrios P Diagnostic yield of liquid-based cytology, immunophenotyping and molecular techniques in lymphomas and other entities in vitrectomy specimens. Invest Ophthalmol Vis Sci 2004, 45:1072.
15. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 1998, 105:1664-1669.
16. White VA, Gascoyne RD, Paton KE Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol 1999, 117:761-765.
17. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995, 120:671-673.
18. Buggage RR, Whitcup SM, Nussenblatt RB, Chan CC Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. Invest Ophthalmol Vis Sci 1999, 40:2462-2463.
19. Akpek EK, Foster CS Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene arrangement. Arch Ophthalmol 2000, 118:731-732.
20. Schanzer MC, Font RL, O'Malley RE Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology 1991, 98:88-91.
21. Margolis L, Fraser R, Lichter A, Char DH The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980, 45:688-692.
22. Sandor V, Stark-Vancs V, Pearson D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998, 16:3000-3006.
23. Hormigo A, DeAngelis LM Primary ocular lymphoma: clinical features, diagnosis, and treatment. Clin Lymphoma 2003, 4:22-29.
24. Batchelor TT, Kolak G, Ciordia R, et al. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003, 9:711-715.
25. Singh AD, Lewis H, Schachat AP Primary lymphoma of the central nervous system. Ophthalmol Clin North Am 2005, 18:199-207. x.
26. Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002, 109:1709-1716.
27. Deangelis LM, Hormigo A Treatment of primary central nervous system lymphoma. Semin Oncol 2004, 31:684-692.
28. Correa DD, DeAngelis LM, Shi W, et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004, 62:548-555.
29. Pels H, Schmidt-Wolf IG, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003, 21:4489-4495.
30. Ferreri AJ, Abrey LE, Blay JY, et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, 12-15 June 2002. J Clin Oncol 2003, 21:2407-2414.
31. Blay JY, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998, 16:864-871.
32. Chang CC, Kampalath B, Schultz C, et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med 2003, 127:208-212.